Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px
Organisation › Details

BioAscent Discovery Ltd.

Founded in 2013, BioAscent is a leading provider of integrated drug discovery services based at the former Organon / Merck Sharpe and Dohme (MSD) R&D site in Newhouse, Scotland. Our drug discovery services include de novo assay development, target analysis and bespoke screening strategies, compound screening, medicinal and synthetic chemistry, computational chemistry and data management. Our team of expert scientists has experience of successfully working from assay development through to preclinical and clinical candidates across all biological target classes and major therapeutic indications. As part of its compound management service, BioAscent currently holds and manages over 1 million compounds for our customers, in both liquid and solid formats. Through the Compound Cloud service, the company provides rapid access to an IP-free library of ~125,000 lead like compounds in screening-ready format. Since 2013, the BioAscent team has been responsible for: >100 biochemical and biophysical assays for drug discovery projects >50 hit validation/characterisation projects >30 hit-to-lead campaigns >80,000 screening plates delivered to our global customers/partners *


Period Start 2013-01-01 established
  Group BioCity (GB) (Group)
Product Industry drug discovery services
Person Person Smith, Paul (BioCity 201707– CEO of BioAscent Discovery before CXR Biosciences CEO)
  Street Bo’Ness Road
  City ML1 5UH Newhouse, Lanarkshire
  Tel +44-1698-534-002
    Address record changed: 2017-07-19
Basic data Employees n. a.
    * Document for �About Section�: BioAscent Discovery Ltd.. (4/12/18). "Press Release: BioAscent Establishes Integrated Drug Discovery Services Offering". Newhouse.
Record changed: 2020-03-28


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for BioCity (GB) (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81

» top